Martin Madden

Martin Madden

Director/Board Member at MICROBOT MEDICAL INC.

Net worth: 516 039 $ as of 2026-05-30

66 year
Health Technology
Consumer Services

Profile

Martin J.
Madden
is currently an Independent Director at NovoCure Ltd. since 2017 and an Independent Director at Microbot Medical, Inc. since 2017.
Former positions include Independent Director at TSO3, Inc. from 2018 to 2019, Director at Mardil, Inc., Vice President-Medical Device R&D Transformation at Johnson & Johnson from 2016 to 2017, and Vice President-Research & Development at DePuy Synthes, Inc. from 1986 to 2017.
Education includes graduate studies at Carnegie Mellon University, an MBA from The Trustees of Columbia University in The City of New York, and undergraduate studies at the University of Dayton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-02 30,284 ( 0.03% ) 516 039 $ 2026-05-30
2026-03-31 0 ( -.--% ) - $ 2026-05-30

Martin Madden active positions

CompaniesPositionStart
MICROBOT MEDICAL INC. Director/Board Member 2017-02-05
NOVOCURE LIMITED Director/Board Member 2017-05-09

Former positions of Martin Madden

CompaniesPositionEnd
TSO3 INC. Director/Board Member 2019-09-30
Chief Tech/Sci/R&D Officer 2016-12-31
JOHNSON & JOHNSON Chief Tech/Sci/R&D Officer 2015-06-30
Director/Board Member -
See the detail of Martin Madden's experience

Training of Martin Madden

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

88

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!